Search research articles
Contact Us
Filters
Showing results (21-30 of 93) with videos related to
Page
of 10
Sort By:
American Journal of Hematology
|
March 8, 2016
Deferasirox and children: From clinical trials to the real world
Raffaella Origa, Antonietta Zappu, Maria Loreta Foschini, et al.
Blood Cells, Molecules & Diseases
|
July 31, 2013
Complexity of the alpha-globin genotypes identified with thalassemia screening in Sardinia
Raffaella Origa, Maria E Paglietti, Maria C Sollaino, et al.
American Journal of Hematology
|
April 21, 2018
Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias
Raffaella Origa, Antonio Piga, Immacolata Tartaglione, et al.
Haematologica
|
October 13, 2005
Combined therapy with deferiprone and desferrioxamine in thalassemia major
Raffaella Origa, Patrizio Bina, Annalisa Agus, et al.
Experimental Hematology & Oncology
|
August 15, 2020
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study
Immacolata Tartaglione, Raffaella Origa, Antonis Kattamis, et al.
American Journal of Hematology
|
December 30, 2016
EPO and hepcidin plasma concentrations in blood donors and β-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations
Nienke Schotten, Coby M M Laarakkers, Rian W Roelofs, et al.
Blood Transfusion = Trasfusione Del Sangue
|
July 18, 2025
Transfusion strategies in thalassemia and sickle cell disease SITE-SIMTI-SIdEM Good Practice
Gian Luca Forni, Aurora Vassanelli, Lucia De Franceschi, et al.
American Journal of Hematology
|
January 2, 2024
'Phenoconversion' in adult patients with β-thalassemia
Khaled M Musallam, Susanna Barella, Raffaella Origa, et al.
Annals of Hematology
|
March 20, 2024
Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study
Khaled M Musallam, Susanna Barella, Raffaella Origa, et al.
Blood Cells, Molecules & Diseases
|
May 31, 2024
Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent β-thalassemia patients who remained on the same monotherapy over 10 years
Khaled M Musallam, Susanna Barella, Raffaella Origa, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 93) with videos related to
Sort By:
Page
of 10
American Journal of Hematology
|
March 8, 2016
Deferasirox and children: From clinical trials to the real world
Raffaella Origa, Antonietta Zappu, Maria Loreta Foschini, et al.
Blood Cells, Molecules & Diseases
|
July 31, 2013
Complexity of the alpha-globin genotypes identified with thalassemia screening in Sardinia
Raffaella Origa, Maria E Paglietti, Maria C Sollaino, et al.
American Journal of Hematology
|
April 21, 2018
Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias
Raffaella Origa, Antonio Piga, Immacolata Tartaglione, et al.
Haematologica
|
October 13, 2005
Combined therapy with deferiprone and desferrioxamine in thalassemia major
Raffaella Origa, Patrizio Bina, Annalisa Agus, et al.
Experimental Hematology & Oncology
|
August 15, 2020
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study
Immacolata Tartaglione, Raffaella Origa, Antonis Kattamis, et al.
American Journal of Hematology
|
December 30, 2016
EPO and hepcidin plasma concentrations in blood donors and β-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations
Nienke Schotten, Coby M M Laarakkers, Rian W Roelofs, et al.
Blood Transfusion = Trasfusione Del Sangue
|
July 18, 2025
Transfusion strategies in thalassemia and sickle cell disease SITE-SIMTI-SIdEM Good Practice
Gian Luca Forni, Aurora Vassanelli, Lucia De Franceschi, et al.
American Journal of Hematology
|
January 2, 2024
'Phenoconversion' in adult patients with β-thalassemia
Khaled M Musallam, Susanna Barella, Raffaella Origa, et al.
Annals of Hematology
|
March 20, 2024
Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study
Khaled M Musallam, Susanna Barella, Raffaella Origa, et al.
Blood Cells, Molecules & Diseases
|
May 31, 2024
Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent β-thalassemia patients who remained on the same monotherapy over 10 years
Khaled M Musallam, Susanna Barella, Raffaella Origa, et al.
Page
of 10